110 related articles for article (PubMed ID: 15301941)
21. Further characterization of the stimulus properties of 5,6,7,8-tetrahydro-1,3-dioxolo[4,5-g]isoquinoline.
Glennon RA; Young R; Rangisetty JB
Pharmacol Biochem Behav; 2002 May; 72(1-2):379-87. PubMed ID: 11900809
[TBL] [Abstract][Full Text] [Related]
22. Discriminative stimulus properties of alpha-ethyltryptamine optical isomers.
Hong SS; Young R; Glennon RA
Pharmacol Biochem Behav; 2001; 70(2-3):311-6. PubMed ID: 11701202
[TBL] [Abstract][Full Text] [Related]
23. Behavioral and neurochemical pharmacology of six psychoactive substituted phenethylamines: mouse locomotion, rat drug discrimination and in vitro receptor and transporter binding and function.
Eshleman AJ; Forster MJ; Wolfrum KM; Johnson RA; Janowsky A; Gatch MB
Psychopharmacology (Berl); 2014 Mar; 231(5):875-88. PubMed ID: 24142203
[TBL] [Abstract][Full Text] [Related]
24. Cocaine--stimulus generalization to MDA optical isomers: a reevaluation.
Young R; Glennon RA
Pharmacol Biochem Behav; 1997; 57(1-2):115-8. PubMed ID: 9164561
[TBL] [Abstract][Full Text] [Related]
25. Discriminative stimulus properties of MDA analogs.
Glennon RA; Young R; Rosecrans JA; Anderson GM
Biol Psychiatry; 1982 Jul; 17(7):807-14. PubMed ID: 6126227
[TBL] [Abstract][Full Text] [Related]
26. Discriminative stimulus and locomotor effects of para-substituted and benzofuran analogs of amphetamine.
Dolan SB; Forster MJ; Gatch MB
Drug Alcohol Depend; 2017 Nov; 180():39-45. PubMed ID: 28865391
[TBL] [Abstract][Full Text] [Related]
27. DOM-stimulus generalization to LSD and other hallucinogenic indolealkylamines.
Glennon RA; Young R; Jacyno JM; Slusher M; Rosecrans JA
Eur J Pharmacol; 1983 Jan; 86(3-4):453-9. PubMed ID: 6572591
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the discriminative stimulus effects of 3,4-methylenedioxymethamphetamine (MDMA) and cocaine: asymmetric generalization.
Khorana N; Pullagurla MR; Young R; Glennon RA
Drug Alcohol Depend; 2004 Jun; 74(3):281-7. PubMed ID: 15194206
[TBL] [Abstract][Full Text] [Related]
29. Behavioral characterization of 2-O-desmethyl and 5-O-desmethyl metabolites of the phenylethylamine hallucinogen DOM.
Eckler JR; Chang-Fong J; Rabin RA; Smith C; Teitler M; Glennon RA; Winter JC
Pharmacol Biochem Behav; 2003 Jul; 75(4):845-52. PubMed ID: 12957227
[TBL] [Abstract][Full Text] [Related]
30. Differences in the stimulus properties of 3,4-methylenedioxyamphetamine and 3,4- methylenedioxymethamphetamine in animals trained to discriminate hallucinogens from saline.
Callahan PM; Appel JB
J Pharmacol Exp Ther; 1988 Sep; 246(3):866-70. PubMed ID: 2901488
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and evaluation of 2,3-dihydrobenzofuran analogues of the hallucinogen 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane: drug discrimination studies in rats.
Nichols DE; Hoffman AJ; Oberlender RA; Riggs RM
J Med Chem; 1986 Feb; 29(2):302-4. PubMed ID: 3950910
[TBL] [Abstract][Full Text] [Related]
32. The stimulus effect of 5,6,7,8-tetrahydro-1,3-dioxolo[4,5-g]isoquinoline is similar to that of cocaine but different from that of amphetamine.
Young R; Glennon RA
Pharmacol Biochem Behav; 2002; 71(1-2):205-13. PubMed ID: 11812524
[TBL] [Abstract][Full Text] [Related]
33. A preliminary investigation of the psychoactive agent 4-bromo-2,5-dimethoxyphenethylamine: a potential drug of abuse.
Glennon RA; Titeler M; Lyon RA
Pharmacol Biochem Behav; 1988 Jul; 30(3):597-601. PubMed ID: 3211969
[TBL] [Abstract][Full Text] [Related]
34. Stimulus properties of 1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDA) analogs.
Glennon RA; Yousif M; Patrick G
Pharmacol Biochem Behav; 1988 Mar; 29(3):443-9. PubMed ID: 2896360
[TBL] [Abstract][Full Text] [Related]
35. Discriminative stimulus effects of N,N-diisopropyltryptamine.
Carbonaro TM; Forster MJ; Gatch MB
Psychopharmacology (Berl); 2013 Mar; 226(2):241-6. PubMed ID: 23070023
[TBL] [Abstract][Full Text] [Related]
36. Involvement of adenosine A1 and A2A receptors in the adenosinergic modulation of the discriminative-stimulus effects of cocaine and methamphetamine in rats.
Justinova Z; Ferre S; Segal PN; Antoniou K; Solinas M; Pappas LA; Highkin JL; Hockemeyer J; Munzar P; Goldberg SR
J Pharmacol Exp Ther; 2003 Dec; 307(3):977-86. PubMed ID: 14557381
[TBL] [Abstract][Full Text] [Related]
37. Nefazodone in the rat: mimicry and antagonism of [-]-DOM-induced stimulus control.
Eckler JR; Rabin RA; Winter JC
Pharmacol Biochem Behav; 2003 May; 75(2):405-10. PubMed ID: 12873632
[TBL] [Abstract][Full Text] [Related]
38. Discriminative stimulus properties of (-)ephedrine.
Young R; Glennon RA
Pharmacol Biochem Behav; 1998 Jul; 60(3):771-5. PubMed ID: 9678664
[TBL] [Abstract][Full Text] [Related]
39. 1-(2,3-Methylenedioxyphenyl)-2-aminopropane (2,3-MDA): a preliminary investigation.
Glennon RA; Young R; Soine W
Gen Pharmacol; 1984; 15(4):361-2. PubMed ID: 6149169
[TBL] [Abstract][Full Text] [Related]
40. Discriminative stimulus effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane in rhesus monkeys.
Li JX; Rice KC; France CP
J Pharmacol Exp Ther; 2008 Feb; 324(2):827-33. PubMed ID: 17993605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
